Ombitasvir

Bibliografia - Quali fonti bibliografiche per Ombitasvir?

1. Andreone P. et al., Gastroenterology, 2014, 147 (2), 359.


2. Badri P.S. et al., Antimicrob. A. Chemother., 2016, 60 (1), 105.


3. Badri P.S. et al., Clin. Pharmacokinet., 2016a, 55 (3), 275.


4. Deeks E.D., Drugs, 2015, 75, 1027.


5. El-Sherif O., Back D., Curr HIV/AIDS Rep., 2015, 12 (3), 336.


6. European Medicines Agency – EMA, EMA/263596/2016, 15 Aprile.


7. European Medicines Agency – EMA, EMA/795452/2016, 2016a, 2 Dicembre.


8. Feld J.J. et al., NEJM, 2014, 370 (17), 1594.


9. Ferenci P., NEJM, 2014, 370 (21), 1983.


10. Food and Drug Administration – FDA, 2016, Drug Safety and Availability, 4 ottobre http://www.fda.gov/Drugs/DrugSafety/ucm522932.htm (accesso: ottobre 2016).


11. Gentile I. et al., Expert. Rev. Anti. Infect. Ther., 2014, 12 (9), 1033.


12. Hézode C. et al., Lancet., 2015, 385 (9986), 2502.


13. Khatri A. et al., J. Hepatol., 2015, 63 (4), 805.


14. Krishnan P. et al., Antimicrob. A. Chemother., 2015, 59 (2), 979.


15. Krishnan P. et al., Antimicrob. A. Chemother., 2015a, 59 (9), 5445.


16. Kwo P.Y. et al., NEJM, 2014, 371, 2375.


17. Lam B.P. et al., Therap. Adv. Gastroenterol., 2015, 8 (5), 298.


18. Menon R.M. et al., J. Hepatol., 2015, 63 (1), 20.


19. Mensing S. et al., AAPS J., 2016, 18 (19), 270.


20. Poordad F., NEJM, 2014, 370 (21), 1973.


21. Raedler L.A., Am. Health Drug Benefits, 2015, 8, 142.


22. Reig M. et al., J. Hepatol., 2016.


23. Smith M.A., Lim A., Drug Des. Devel. Ther., 2015, 9, 6083.


24. Sulkowski M.S. et al., JAMA, 2015, 313 (12), 1223.


25. Spera A.M. et al., World J. Hepatol., 2016, 8 (12), 557.


26. Zeuzem S. et al., NEJM, 2014, 370 (17), 1604.